phase i/ii trial of zenocutuzumab for tumors with nrg1 fusions
Published 3 years ago • 373 plays • Length 4:03Download video MP4
Download video MP3
Similar videos
-
1:29
enrgy: zenocutuzumab in nrg1 fusion–positive tumors
-
1:56
enrgy: zenocutuzumab in nrg1 fusion-positive nsclc
-
0:46
enrgy: zenocutuzumab in nrg1 fusion-positive pancreatic ductal adenocarcinoma
-
12:49
nrg1 fusion-driven tumors: biology, detection, and role of afatinib and other erbb-targeting agents
-
1:49
a phase ii study of i-sabr in early or recurrent nsclc
-
9:16
behind the mystery: nrg1 fusions
-
0:34
rational for her3-targeting in nrg1 fusion-positive nsclc
-
0:54
phase ib/ii trial of 177lu-girentuximab with cabozantinib and nivolumab in clear cell rcc
-
2:31
dr. duruisseaux on the incidence of nrg1 fusions in solid tumors
-
0:51
assessing i-sabr in early or recurrent non-small cell lung cancer
-
24:42
mechanisms of lung tumorigenesis by mutant egfr
-
3:00
phase ii randomized trial of conventional vs hypofractionated post-mastectomy proton radiotherapy
-
3:16
synthesis, preclinical analysis, and first-inhuman phase i imaging of 89zr-dfodaratumumab for cd...
-
4:50
ngs across tumor types for trk inhibition
-
0:58
use of parp1-selective and atr inhibitors to target ddr signalling pathway
-
7:21
neo-aegis: preliminary results of the phase iii rct of cross versus perioperative chemotherapy
-
2:45
dr. liu on nrg1 fusions in oncology
-
1:05
differences of response to io /- chemotherapy or io in nsclc depending on pd-l1 expression levels
-
55:27
induction of receptor tyrosine kinase signaling from lung adenocarcinoma